MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells
Triple-negative breast cancer shows worse outcome compared with other subtypes of breast cancer. The discovery of dysregulated microRNAs and their roles in the progression of triple-negative breast cancer provide novel strategies for the treatment of patients with triple-negative breast cancer. In t...
Main Authors: | Guochen Zhang MD, Junlan Wang BS, Ruilin Zheng MD, Beibei Song BS, Li Huang PhD, Yujiang Liu MD, Yating Hao MD, Xiangdong Bai PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-05-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/1533033820927011 |
Similar Items
-
Expression of MicroRNAs (miR-15b, miR-16, miR-138, miR-221, and miR-222) as Biomarkers of Endothelial Corpus Cavernosum Dysfunction in a Diabetic Alcoholic Murine Model
by: Ricardo Brianezi Tiraboschi, MD, PhD, et al.
Published: (2021-04-01) -
Yes-Associated Protein (YAP) Facilitates Pressure Overload–Induced Dysfunction in the Diabetic Heart
by: Shohei Ikeda, MD, PhD, et al.
Published: (2019-09-01) -
miR-29b Mediates the Chronic Inflammatory Response in Radiotherapy-Induced Vascular Disease
by: Suzanne M. Eken, MD, PhD, et al.
Published: (2019-02-01) -
Smad8 Is Increased in Duchenne Muscular Dystrophy and Suppresses miR-1, miR-133a, and miR-133b
by: Alesce, L., et al.
Published: (2022) -
Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the Gene
by: Yajing Huang MD, et al.
Published: (2020-02-01)